As principal and founder of Cline Consulting and a senior executive of Biometrics, my expertise in biostatistics, programming, data management, and decision science, coupled with my experience in data science, AI, drug development governance, and corporate integrations, allows me to develop and implement innovative statistical methods that overachieve targets and mitigate risk.
Expertise in the legal area as an expert witness.
I am known for my exceptional ability to communicate complex analytical methods and strategies effectively, making them vital to the enterprise's decision-making process and fostering team growth.
I aim to leverage methodology and analytics to innovate and transform the biopharmaceutical industry. I dedicate my time and energy to driving the frontiers of science and healthcare forward, and I hope to inspire others to join me in this transformative journey. I am currently serving as the Representative At-Large for the board of the Washington Statistical Society.
Bayesian designs, master protocols, and precision medicine to optimize clinical trials, reduce costs, and improve outcomes
Standard operating procedure implementation and design
Clearly communicate statistical approaches in the language of drug development and market support as a drug developer or expert biostatatistics witness
Analysis planning and execution, governance reviews, and regulatory submissions
Data Monitoring Committee expertise for creation and execution
Coaching for all levels of leaders with specific successful approaches for individual contributors to large group managers
24 - 26 September 2025
Insights from industry, academia, and regulatory agencies in Rockville, MD
02-07 Aug 2025
Statistics, Data Science, and AI Enriching Event in Nashville, Tennessee
16 September 2025
American Association for Public Opinion Research
and
the Washington Statistical Society 2025 Review Preview Conference
See here.